Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Paradigm

Paradigm Micro-Cap Fund (PVIVX)

Ticker PVIVX · · Holdings as of Jun 30, 2026

Expense ratio
1.26%$126/yr per $10k
5-yr return
+5.3%annualized
1-yr return
−4.8%as of Dec 2025
Net assets
$183.4Mall share classes
Holdings
42

Bottom line

Is PVIVX a good fund? The bottom line

PVIVX is an actively managed small-cap mutual fund from Paradigm.

Its expense ratio is 1.26% — about $126 a year on every $10,000 invested, more expensive than 75% of small-cap funds we track.

It returned −4.8% over one year, +5.3% a year over five years, +11.8% a year over ten (as of Dec 31, 2025, per its prospectus).

With $183 million in net assets and 42 holdings, its largest position is Modine Manufacturing Company (11.7%) and the top 10 make up 53.5% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.26%)
  • Concentrated: top 10 holdings are 53.5% of assets

Updated Nov 19, 2026

What PVIVX invests in

? The Paradigm Micro-Cap Fund (the Micro-Cap Fund or the Fund) seeks long-term capital appreciation.

Under normal circumstances, the Micro-Cap Fund invests at least 80% of its net assets in the common stocks of U.S. micro-cap companies. The Fund generally considers a company to be a micro-cap company if, at the time of purchase, its market capitalization is within the range of capitalizations of companies in the Russell Microcap Index as of the most recent reconstitution date. As of March 31, 2026, the range of market capitalizations for the Russell Microcap Index was $3 million to $8.937 billion. The capitalizations of companies within the Russell Microcap Index may increase or decrease due to market conditions. The Fund may be overweight in certain sectors at various times. Stocks are sold when they have realized the value anticipated by the Advisor or if new investment opportunities with higher expected returns are acquired. The Fund may continue to hold stocks of companies whose…

From the fund's prospectus (filed Apr 29, 2026).

PVIVX performance

Fund calendar-year total returns, 2016–2025 2016: +27.3%; 2017: +15.8%; 2018: −11.0%; 2019: +22.4%; 2020: +46.9%; 2021: +27.9%; 2022: −20.6%; 2023: +17.9%; 2024: +13.5%; 2025: −4.8% +27% 2016 +16% 2017 −11% 2018 +22% 2019 +47% 2020 +28% 2021 −21% 2022 +18% 2023 +14% 2024 −5% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
PVIVX−4.8%+5.3%+11.8%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full PVIVX performance history →

What PVIVX costs

On a $10,000 investment, PVIVX's 1.26% expense ratio costs about $126 a year. The prospectus estimates $1,523 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full PVIVX fee table →

PVIVX top 10 holdings

#Holding% of fund
1Modine Manufacturing Company11.65%
2Onto Innovation Inc.8.25%
3Goldman Sachs Trust - Goldman Sachs Financial Square Government Fund Institutional Class6.22%
4QuidelOrtho Corporation4.97%
5Veeco Instruments Inc.4.13%
6Integra Lifesciences Holdings Corporation3.92%
7A10 Networks, Inc.3.83%
8The Pennant Group, Inc.3.63%
9The Ensign Group, Inc.3.50%
10Build-A-Bear Workshop, Inc.3.41%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 53.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to PVIVX

More funds like PVIVX →

PVIVX FAQ

What is the expense ratio of PVIVX?
PVIVX's expense ratio is 1.26%, which works out to about $126 a year for every $10,000 invested. The prospectus estimates total costs of $1,523 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is PVIVX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.26%); concentrated: top 10 holdings are 53.5% of assets. This is general information, not personalized advice.
What does PVIVX hold?
PVIVX's largest holdings are Modine Manufacturing Company (11.7%), Onto Innovation Inc. (8.3%), Goldman Sachs Trust - Goldman Sachs Financial Square Government Fund Institutional Class (6.2%), QuidelOrtho Corporation (5.0%), Veeco Instruments Inc. (4.1%). It holds 42 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is PVIVX's 5-year return?
PVIVX returned +5.3% a year over the five years ending Dec 31, 2025, and +11.8% a year over ten years. Past performance does not guarantee future results.
Does PVIVX have a sales load?
No. PVIVX has no front-end sales charge.
Who manages PVIVX?
PVIVX is offered by Paradigm through Paradigm Funds.